Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep796 | Pituitary and Neuroendocrinology | ECE2023

Octreotide and pasireotide LAR in non-functioning pituitary neuroendocrine tumours treatment

Bogusławska Anna , Kluczyński Łukasz , Godlewska Magdalena , Rzepka Ewelina , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Somatostatin analogues (SSA) are first/second line treatment in the management of acromegaly and Cushing disease (CD), however, recent data suggest that they can be effective in the management of non-functioning pituitary neuroendocrine tumour (PitNET). We present one clinically silent gonadotroph PitNET treated with octreotide and two silent corticotroph PitNETs treated with pasireotide.Case 1: A 50-year-old female presented with frontal headache and vi...

ea0049ep1026 | Pituitary - Clinical | ECE2017

Pituitary insufficiency following traumatic thoracic injury in adolescent male patient-case study

Gilis-Januszewska Aleksandra , Wilusz Malgorzata , Turek-Jabrocka Renata , Pantoflinski Jacek , Trofimiuk-Muldner Malgorzata , Kluczynski Lukasz , Hubalewska-Dydejczyk Alicja , Pach Dorota

Traumatic thoracic injuries in children and adolescents are rare, but could be connected with others traumas, often with traumatic brain injury (TBI). Based on data in the current literature, approximately 15–20% of TBI patients develop chronic hypopituitarism. Growth hormone (GH) and ACTH deficiency are the most common, followed by gonadotropins and thyroid-stimulating hormone. The greatest challenge associated with endocrine complications in individuals with polytrauma ...

ea0041ep280 | Clinical case reports - Pituitary/Adrenal | ECE2016

Pheochromocytoma – the rare reason of Cushing’s syndrome due to ectopic corticotropin secretion

Przybylik-Mazurek Elwira , Rzepka Ewelina , Kurzynska Anna , Hubalewska-Dydejczyk Alicja , Sowa-Staszczak Anna , Budzynski Andrzej , Bialas Magdalena , Chrzan Robert

Cushing syndrome due to ectopic (adrenocorticotropic hormone) ACTH secretion (EAS) constitutes approximately 10% of Cushing’s syndrome (CS). In this group only in about 5% cases pheochromocytoma is the source of ACTH.We present two patients with EAS by pheochromocytoma.1. A 70 year-old woman with 3-months history of malaise, weakness, abdominal pain, loss of weight and appetite, hypertension and diabetes mellitus. One month ea...

ea0041ep300 | Clinical case reports - Pituitary/Adrenal | ECE2016

Temozolomide treatment in pituitary tumor causing Cushing’s Disease resistant to conventional therapy – case report

Gilis-Januszewska Aleksandra , Pantoflinski Jacek , Turek-Jabrocka Renata , Sokolowski Grzegorz , Wilusz Malgorzata , Pach Dorota , Hubalewska-Dydejczyk Alicja

Objective: The management of pituitary tumors causing Cushing’s Disease are a multidisciplinary challenge to clinicians with neurosurgery as a first line treatment followed by the radiotherapy and pharmacotherapy including chemiotherapy.Such tumors are difficult to treat with high rate of recurrence. To date only 25 patients with Cushing Disease treated with the new alkylating agent temozolamide (TMZ) have been reported.Materials and methods: Sixty-...

ea0041ep1023 | Thyroid (non-cancer) | ECE2016

Thyroid function parameters in Polish pregnant women

Trofimiuk-Muldner Malgorzata , Szybinski Zbigniew , Sokolowski Grzegorz , Stefanska Agnieszka , Buziak-Bereza Monika , Adamczewski Zbigniew , Lewinski Andrzej , Hubalewska-Dydejczyk Alicja

Thyroid function in pregnancy differs between populations. The aim of the study was to assess thyroid parameters in Polish pregnant women. It included 1095 pregnant volunteers aged 16–42 years (174, 501, 420 in the 1st, 2nd, and 3rd trimester, respectively), who gave their informed written consent. In each woman thyroid ultrasound was performed, 90.7% had TSH, fT4 and a-TPO measured, and 84.0% iodine urinary concentration (UIC) in urine spot sample estimated.<p class=...

ea0037gp.30.04 | Endocrine tumours and neoplasia – General | ECE2015

Re-introduction of type 1 iodothyronine deiodinase in renal cancer cells affects their migration and expression of adhesion-related genes

Poplawski Piotr , Boguslawska Joanna , Kedzierska Hanna , Rybicka Beata , Tanski Zbigniew , Visser Theo J , Nauman Alicja , Piekielko-Witkowska Agnieszka

Introduction: Type 1 iodothyronine deiodinase (DIO1) is one of the three enzymes regulating bioavailability of thyroid hormones. In contrast to DIO2 and DIO3, the specific cellular role of DIO1 remains controversial. Our previous studies showed that DIO1 expression in clear cell renal cell carcinoma (ccRCC) is decreased, followed by lowered intracellular T3 concentration. In this study we explored how re-introduction of DIO1 in ccRCC cells affects their mig...

ea0035p553 | Endocrine tumours and neoplasia | ECE2014

Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) – 10 year experience of one center

Lewkowicz Ewelina , Trofimiuk-Muldner Malgorzata , Pach Dorota , Kieltyka Agnieszka , Staszczak Agnieszka , Sowa-Staszczak Anna , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

GEPNETs are rare tumors of very variable biology, particularly proliferative potential. Improved knowledge of the clinical course of disease may lead to proper identification of patients requiring more aggressive approach.Aim: i) characteristics of GEP-NET patients of the Endocrinology Department, University Hospital in Krakow, Poland; ii) identification of factors influencing their 5-year survival.Material and methods: Study inclu...

ea0035p554 | Endocrine tumours and neoplasia | ECE2014

Epidemiology of gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area

Trofimiuk-Muldner Malgorzata , Lewkowicz Ewelina , Pach Dorota , Kieltyka Agnieszka , Stefanska Agnieszka , Sowa-Staszczak Anna , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Cancer registers are important tools in improving the knowledge of epidemiology of rare malignancies, such as gastro-entero-pancreatic neuroendocrine tumors.Aim: To assess the epidemiology of GEPNETs in Krakow and Krakow district area between January 2007 and December 2011.Material and methods: To assess the epidemiology of GEPNETs in Krakow area a register was created, based on independent sources of information. 88 patients (49 f...

ea0035p555 | Endocrine tumours and neoplasia | ECE2014

Factors influencing survival of patients diagnosed with gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area

Trofimiuk-Muldner Malgorzata , Lewkowicz Ewelina , Pach Dorota , Kieltyka Agnieszka , Stefanska Agnieszka , Sowa-Staszczak Anna , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Abstract Identification of factors influencing survival of the gastro-entero-pancreatic neuroendocrine tumors patients may improve their management by better selection of subjects requiring more closed follow-up and more aggressive therapeutic approach.Aim: To assess factors influencing survival of GEPNET patients livingin Krakow and Krakow district area.Material and methods: The data from GEPNETs register run in t...

ea0035p585 | Endocrine tumours and neoplasia | ECE2014

Combined therapy PRRT with long acting somatostatin analogue: results of 7 years’ experience

Sowa-Staszczak Anna , Stefanska Agnieszka , Buziak-Bereza Monika , Trofimiuk-Muldner Malgorzata , Mikolajczak Renata , Tomaszuk Monika , Hubalewska-Dydejczyk Alicja

Introduction: The aim of this study was to assess the survival rate of patients with disseminated or inoperable neuroendocrine tumors (NETs) after PRRT with the use of 90Y-DOTATATE combined with long acting somatostatin analogue.Materials and methods: 72 patients were treated with PRRT in our Department. The 90Y-DOTATATE therapeutic activity was calculated per total body surface area up to a total of 7.4 GBq/m2 administra...